Burn and Scald Medicine Research:CAGR of 3.9% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Burn and Scald Medicine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.



The global market for Burn and Scald Medicine was estimated to be worth US$ 454 million in 2024 and is forecast to a readjusted size of US$ 601 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.



【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】

https://www.qyresearch.com/reports/3605633/burn-and-scald-medicine



Burn and Scald Medicine Market Summary

According to the new market research report "Global Burn and Scald Medicine Market Report 2024-2030", published by QYResearch, the global Burn and Scald Medicine market size is projected to reach USD 0.6 billion by 2030, at a CAGR of 3.9% during the forecast period.

Global Burn and Scald Medicine MarketSize(US$ Million), 2020-2031
250331-162951.webp (14 KB)

Above data is based on report from QYResearch: Global Burn and Scald Medicine Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.

Global Burn and Scald Medicine Top31Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)
250331-163017.webp (31 KB)

Above data is based on report from QYResearch: Global Burn and Scald Medicine Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of Burn and Scald Medicine include Mebao Pharmaceutical Technology Group, B. Braun, Integra LifeSciences, Jinyao Darentang, Smith & Nephew, etc. In 2023, the global top five players had a share approximately 43.0% in terms of revenue.

According to QYResearch Top Players Research Center, the global key manufacturers of Burn and Scald Medicine include Mebao Pharmaceutical Technology Group, B. Braun, Integra LifeSciences, Jinyao Darentang, Smith & Nephew, Yangtze River Pharmaceutical Group, STADA Thornton & Ross, Kenvue Brands LLC, Changchun Overseas Pharmaceutical Group Co., Ltd., Orkla Health, etc. In 2023, the global top 10 players had a share approximately 49.0% in terms of revenue.

Burn and Scald Medicine,Global Market Size, Split by Product Segment
250331-163041.webp (25 KB)

Based on or includes research from QYResearch: Global Burn and Scald Medicine Market Report 2024-2030.

In terms of product type, currently Ointment is the largest segment, hold a share of 52.9%.

In terms of product application, currently Hospitals and Clinics is the largest segment, hold a share of 52.6%.

The increasing aging of the population has increased the proportion of burns and scalds caused by accidents such as falls and scalds among the elderly, thus driving the demand for the burn and scald drug market. The frequent occurrence of industrial accidents and the accelerated pace of life have also increased the incidence of burns and scalds, further expanding the market demand.

The continuous advancement of medical technology, especially the application of biotechnology and nanotechnology in burn treatment, has brought new development opportunities to the burn and scald drug industry.

The research and development of new drugs, such as growth factors and skin regeneration factors, have provided new treatment methods for burn and scald treatment, improved the treatment effect, and met the diverse needs of patients.

The state has issued a series of policies and regulations for the field of burn and scald drugs, aiming to regulate the market order and ensure the safety of patients' medication. These regulations provide legal protection for the burn and scald drug industry and promote the healthy development of the industry.

Policy support and supervision guide enterprises to increase R&D investment, promote the development of new drugs, promote industrial upgrading, and bring more development opportunities to the industry.

Favorable measures of the government, such as compensation policies covering almost 70-100% of treatment costs, enable patients to choose advanced burn care treatment. The presence of governmental organizations, such as the World Health Organization (WHO), and non-profit organizations, such as the American Burn Association (ABA), have also helped to raise awareness levels. WHO has been working with the International Society for Burn Injuries and other such organizations to develop strategies to improve burn care worldwide and prevent such injuries. Non-profit organizations that aim to provide and disseminate knowledge about optimal treatment and rehabilitation after burns, such as the British Burn Association and the Canadian Burn Nurses Association, are also raising awareness levels.







The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.



The Burn and Scald Medicine market is segmented as below:

By Company

Mebao Pharmaceutical Technology Group
B. Braun
Integra LifeSciences
Jinyao Darentang
Smith & Nephew
Yangtze River Pharmaceutical Group
STADA Thornton & Ross
Kenvue Brands LLC
Changchun Overseas Pharmaceutical Group Co., Ltd.
Orkla Health
Guangdong Hengjian Pharmaceutical
Otsuka Pharmaceutical Co., Ltd.
Tonghua Maoxiang Pharmaceutical Co., Ltd.
Cipla
Tanabe Mitsubishi Pharmaceuticals
Chongqing Xixuan Biotechnology Co., Ltd.
Quest Products, LLC
Jianmin Group Yekai Thai Pharmaceutical (Suizhou)
Acme United Corp.
Dongwha Pharm
China Resources Pharmaceutical Group
Safetec Of America
Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.
North China Pharmaceutical Hebei Huanuo
Xiangxi Hongcheng Pharmaceutical
Hebei Aoxing Group Pharmaceuticals
Jilin Aodong Pharmaceutical Group
Beijing Tongrentang
Henan Quanyu Pharmaceuticals
Chengdu First Pharmaceuticals



Segment by Type

Ointment
Spray
Oil
Other



Segment by Application

Hospitals and Clinics
Retail Pharmacies
E-commerce Platforms
Other



Each chapter of the report provides detailed information for readers to further understand the Burn and Scald Medicine market:

Chapter 1: Introduces the report scope of the Burn and Scald Medicine report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2020-2031)

Chapter 2: Detailed analysis of Burn and Scald Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2020-2025)

Chapter 3: Provides the analysis of various Burn and Scald Medicine market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2020-2031)

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2020-2031)

Chapter 5: Sales, revenue of Burn and Scald Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2020-2031)

Chapter 6: Sales, revenue of Burn and Scald Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.(2020-2031)

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2020-2025)

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.



Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth Burn and Scald Medicine competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides Burn and Scald Medicine comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides Burn and Scald Medicine market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.



Other relevant reports of QYResearch:

Global Burn and Scald Medicine Market Insights, Forecast to 2031
Global Burn and Scald Medicine Market Research Report 2025
Global Burn and Scald Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

About Us:

QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

This release was published on openPR.